Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich^LMU Molecular Tumor Board.

ABSTRACT:

Background

In pancreatic cancer, systemic treatment options in addition to chemotherapy remain scarce, and so far only a small proportion of patients benefit from targeted therapies.

Objective

The patients with pancreatic cancer discussed in the CCCMunich^LMU Molecular Tumor Board were reviewed to gain a better real-world understanding of the challenges and chances of precision oncology in this hard-to-treat cancer.

Methods

Patients with pancreatic cancer who received comprehensive genomic profiling and were discussed in the interdisciplinary Molecular Tumor Board between May 2017 and July 2022 were included. These patients' medical charts, comprehensive genomic profiling results, and Molecular Tumor Board recommendations were analyzed in this retrospective

SUBMITTER: Dorman K 

PROVIDER: S-EPMC10042756 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature